Acuta Capital Partners’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.02M	Sell	592,108 -460,887	-44%	-$4.39M	3.57%	9
2025 Q4	$12.8M	Sell	1,052,995 -112,211	-10%	-$1.36M	8.68%	4
2025 Q3	$13.6M	Buy	1,165,206 +150,266	+15%	+$1.8M	14.08%	1
2025 Q2	$9.42M	Sell	1,014,940 -204,784	-17%	-$1.6M	13.15%	1
2025 Q1	$8.94M	Buy	1,219,724 +108,653	+10%	+$835K	10.37%	1
2024 Q4	$9.49M	Sell	1,111,071 -79,000	-7%	-$771K	9.55%	1
2024 Q3	$10.4M	Sell	1,190,071 -1,581,059	-57%	-$13M	8.39%	2
2024 Q2	$19M	Buy	2,771,130 +135,843	+5%	+$839K	15.98%	1
2024 Q1	$24M	Buy	2,635,287 +1,325,287	+101%	+$9.41M	15.58%	1
2023 Q4	$5.84M	Buy	+1,310,000	New	+$3.87M	3.29%	13
2022 Q3	–	Sell	-13,171	Closed	-$53K	–	53
2022 Q2	$53K	Buy	+13,171	New	+$49.8K	0.03%	42